Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO
01 Apr 2024 //
PR NEWSWIRE
Aculys delivers positive Phase 3 study interim analysis result of a diazepam
18 Oct 2023 //
PR NEWSWIRE
Aculys Pharma Initiates Phase 3 Trial of Pitolisant
24 Jan 2023 //
BUSINESSWIRE
Aculys Pharma and Four H Initiate Research Collaboration
24 Jan 2023 //
BUSINESSWIRE
Aculys Pharma and SUSMED Sign Contract for Trial Utilizing Blockchain Technology
12 Jul 2022 //
BUSINESSWIRE